Cresco Labs (CRLBF) Net Cash Flow Growth (3y) (2023 - 2025)
Cresco Labs (CRLBF) Net Cash Flow Growth (3y) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.97 Bn | 87.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.26 Bn | 30.32 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.15 Bn | 21.00 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.86 Bn | 16.55 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | -62.71% |
| 10 | Cresco Labs | 258.60 Mn | 195.03 Mn | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.47% |
| Sep 30, 2025 | -55.74% |
| Jun 30, 2025 | 32.25% |
| Mar 31, 2025 | 26.54% |
| Dec 31, 2024 | 18.58% |
| Sep 30, 2024 | -24.64% |
| Dec 31, 2023 | -27.14% |
| Sep 30, 2023 | 74.71% |